Skip to content

Evaluation of Wear Experience With a Weekly Replacement Soft Contact Lens in Neophyte Lens Wearers With Astigmatism

Evaluation of Wear Experience With a Weekly Replacement Soft Contact Lens in Neophyte Lens Wearers With Astigmatism

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06751225
Enrollment
40
Registered
2024-12-27
Start date
2025-01-21
Completion date
2025-11-04
Last updated
2026-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Astigmatism Bilateral

Brief summary

This open-label study is of adults with astigmatism who have never worn contact lenses. Subjects will be fit into a one week planned-replacement contact lenses and will wear lenses for approximately 3 weeks. Subjects will return for vision and lens fit assessments and will complete surveys about their wear experience.

Interventions

DEVICEOne week replacement soft contact lenses

One week replacement soft contact lenses

Sponsors

Ohio State University
Lead SponsorOTHER
Alcon Research
CollaboratorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Subjects will be fit into the one week replacement soft contact lens to wear for 3 weeks.

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

1. Subjects must be new to contact lenses and have astigmatism of -0.75 or greater (within the parameters available for the P7fA lenses) 2. Subjects must have 20/20 or better best corrected visual acuity. 3. Good general health (defined by medication use that has not changed within the last month and the absence of medical conditions or treatments that are deemed confounding to the data as determined by the PI) 4. Ability to give informed consent 5. Willing to spend time for the study. Subjects will be required to attend three study visits and wear contact lenses on days between study visits. 6. Willing and able to wear contact lenses for at least 8 hours per day for 5 days per week during the study as daily wear. 7. Currently not using eye lubricating drops and willing to not use during study. 8. Either gender and 18-40 years of age. 9. Any racial or ethnic origin

Exclusion criteria

1. Any active ocular inflammation or infection. 2. Has a systemic condition that in the opinion of the investigator may affect a study outcome variable. 3. Are presbyopic and require or habitually uses reading glasses for near work 4. Is using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable 5. History of refractive surgery 6. Meets the diagnosis of dry eye disease with OSDI screening score ≥13. 7. Known history of allergy or sensitivity to contact lens solutions and/or sodium fluorescein 8. Is pregnant or lactating or planning a pregnancy during enrollment in the study 9. Is participating in another clinical research study that includes invasive ocular tests 10. An inability to perform contact lens application and removal after instruction.

Design outcomes

Primary

MeasureTime frameDescription
Subjective Assessment of Lens Wear ExperienceAfter 3 weeks of lens wearVAS assessment of overall vision. (0-100 scale; 0=unacceptable 100=excellent)

Countries

United States

Baseline characteristics

Characteristic
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
40 Participants
Age, Continuous27.25 years
STANDARD_DEVIATION 5.9
Ethnicity (NIH/OMB)
Hispanic or Latino
6 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
34 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
14 Participants
Race (NIH/OMB)
Black or African American
1 Participants
Race (NIH/OMB)
More than one race
1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
24 Participants
Region of Enrollment
United States
40 participants
Sex: Female, Male
Female
27 Participants
Sex: Female, Male
Male
13 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 40
other
Total, other adverse events
3 / 40
serious
Total, serious adverse events
0 / 40

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 5, 2026